Back to Search
Start Over
Role of nitric oxide and WNK-SPAK/OSR1-KCC2 signaling in daily changes in GABAergic inhibition in the rat dorsal raphe neurons.
- Source :
-
Neuropharmacology [Neuropharmacology] 2018 Jun; Vol. 135, pp. 355-367. Date of Electronic Publication: 2018 Mar 27. - Publication Year :
- 2018
-
Abstract
- Serotonergic neurons in the dorsal raphe nucleus (DRN) act as wake-inducing neurons in the sleep-wake cycle and are controlled by gamma-aminobutyric acid (GABA) synaptic inputs. We investigated daily changes in GABAergic inhibition of the rat DRN neurons and the role of nitric oxide (NO) and cation-chloride co-transporters in the GABAergic action. Neuronal NO synthase (nNOS) was co-expressed in 74% of serotonergic DRN neurons and nNOS expression was higher during daytime (the sleep cycle) than that during nighttime (the wake cycle). GABAergic hyperpolarization of DRN neurons produced by GABA <subscript>A</subscript> receptor agonist muscimol was greater and the equilibrium potential of muscimol showed a hyperpolarizing shift during daytime compared to that during nighttime. Expression levels of potassium-chloride co-transporter 2 (KCC2) were higher during daytime than that during nighttime, whereas there were no changes in sodium-potassium-chloride co-transporter 1 (NKCC1) expression. With-no-lysine kinase (WNK) isoform 1 was more highly expressed during daytime than that during nighttime. Total Ste20-related proline alanine rich kinase (SPAK) and oxidative stress response kinase 1 (OSR1) were also higher during daytime than during nighttime, while there were no changes in phosphorylated SPAK and OSR1. Consistent with the findings during the sleep-wake cycle, ex vivo treatment of DRN slices with a NO donor sodium nitroprusside (SNP) increased the expression of KCC2, WNK1, WNK2, WNK3, SPAK, and OSR1, whilst decreasing phosphorylated SPAK. These results suggest that GABAergic synaptic inhibition of DRN serotonergic neurons shows daily changes during the sleep-wake cycle, which might be regulated by daily changes in nNOS-derived NO and WNK-SPAK/OSR1-KCC2 signaling.<br /> (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Circadian Rhythm drug effects
Dorsal Raphe Nucleus drug effects
Neural Inhibition drug effects
Neural Inhibition physiology
Neurons drug effects
Nitric Oxide Donors pharmacology
Nitric Oxide Synthase Type I metabolism
Protein Kinases metabolism
Protein Serine-Threonine Kinases metabolism
Rats, Sprague-Dawley
Receptors, GABA-A metabolism
Signal Transduction drug effects
Sleep drug effects
Sleep physiology
Solute Carrier Family 12, Member 2 metabolism
Tissue Culture Techniques
WNK Lysine-Deficient Protein Kinase 1 metabolism
K Cl- Cotransporters
Circadian Rhythm physiology
Dorsal Raphe Nucleus metabolism
Neurons metabolism
Nitric Oxide metabolism
Symporters metabolism
gamma-Aminobutyric Acid metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7064
- Volume :
- 135
- Database :
- MEDLINE
- Journal :
- Neuropharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 29596900
- Full Text :
- https://doi.org/10.1016/j.neuropharm.2018.03.035